(Q81196215)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18450120%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

title

Effect of sublingual immunotherapy with grass monomeric allergoid on allergen-specific T-cell proliferation and interleukin 10 production (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18450120%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

1 reference

Samuele E Burastero

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18450120%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Gianni Mistrello

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18450120%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Paolo Falagiani

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18450120%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Clara Paolucci

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18450120%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Daniela Breda

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18450120%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Daniela Roncarolo

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18450120%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Stefania Zanotta

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18450120%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Giorgio Monasterolo

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18450120%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

Renato E Rossi

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18450120%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

publication date

1 April 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18450120%20AND%20SRC:MED&resulttype=core&format=json

Annals of Allergy, Asthma & Immunology

6 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18450120%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

volume

100

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18450120%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18450120%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

page(s)

343-350

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18450120%20AND%20SRC:MED&resulttype=core&format=json

Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper

6 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960597-2

7 January 2021

Allergen immunotherapy decreases interleukin 4 production in CD4+ T cells from allergic individuals

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960597-2

7 January 2021

Immunotherapy: 1999-2004.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960597-2

7 January 2021

Role of interleukin 10 in specific immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960597-2

7 January 2021

Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960597-2

7 January 2021

Noninjection routes for immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960597-2

7 January 2021

Sublingual immunotherapy for allergic rhinitis: an update

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960597-2

7 January 2021

Coseasonal sublingual immunotherapy reduces the development of asthma in children with allergic rhinoconjunctivitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960597-2

7 January 2021

Allergic rhinitis and its impact on asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960597-2

7 January 2021

Sublingual immunotherapy for allergic rhinitis: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960597-2

7 January 2021

Absorption and distribution kinetics of the major Parietaria judaica allergen (Par j 1) administered by noninjectable routes in healthy human beings

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960597-2

7 January 2021

Pharmacokinetics of Der p 2 allergen and derived monomeric allergoid in allergic volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960597-2

7 January 2021

Clinical and immunologic effects of a rush sublingual immunotherapy to Parietaria species: A double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960597-2

7 January 2021

Three-year follow-up of clinical and inflammation parameters in children monosensitized to mites undergoing sub-lingual immunotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960597-2

7 January 2021

Sublingual immunotherapy with Dermatophagoides monomeric allergoid down-regulates allergen-specific immunoglobulin E and increases both interferon-gamma- and interleukin-10-production

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960597-2

7 January 2021

Bacillus Calmette-Guérin-induced interleukin-12 did not additionally improve clinical and immunologic parameters in asthmatic children treated with sublingual immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960597-2

7 January 2021

Sublingual immunotherapy in children modulates allergen-induced in vitro expression of cytokine mRNA in PBMC.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960597-2

7 January 2021

Induction of interleukin 10 by sublingual immunotherapy for house dust mites: a preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960597-2

7 January 2021

Lack of detectable alterations in immune responses during sublingual immunotherapy in children with seasonal allergic rhinoconjunctivitis to grass pollen.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960597-2

7 January 2021

Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960597-2

7 January 2021

Does chronic smoking influence fibrinolytic potential in type 1 diabetes mellitus?

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960597-2

7 January 2021

CD4(+) regulatory T cells

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960597-2

7 January 2021

Specific immunotherapy with SQ standardized grass allergen tablets in asthmatics with rhinoconjunctivitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960597-2

7 January 2021

Multiple daily administrations of low-dose sublingual immunotherapy in allergic rhinoconjunctivitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960597-2

7 January 2021

Detection of specific polymerase chain reaction product by utilizing the 5'----3' exonuclease activity of Thermus aquaticus DNA polymerase

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960597-2

7 January 2021

Immunological basis for IgE hyper-production in enfuvirtide-treated HIV- positive patients

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960597-2

7 January 2021

Decrease of allergen-specific T-cell response induced by local nasal immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960597-2

7 January 2021

Inhibition of allergen-IgE binding to B cells by IgG antibodies after grass pollen immunotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960597-2

7 January 2021

Mechanisms of immunotherapy: IgG revisited

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960597-2

7 January 2021

IgE-facilitated antigen presentation: role in allergy and the influence of allergen immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960597-2

7 January 2021

Mechanisms of immunotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960597-2

7 January 2021

Systemic immunological changes induced by administration of grass pollen allergens via the oral mucosa during sublingual immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960597-2

7 January 2021

Absence of systemic immunologic changes during dose build-up phase and early maintenance period in effective specific sublingual immunotherapy in children

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960597-2

7 January 2021

A pilot study of feasibility of ultra-rush (20-25 minutes) sublingual-swallow immunotherapy in 679 patients (699 sessions) with allergic rhinitis and/or asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960597-2

7 January 2021

Possible relationship between systemic side effects and sensitization to rPar j 2 in allergic patients submitted to an ultra-rush (20 min) sublingual immunotherapy and selected by component resolved diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960597-2

7 January 2021

10.1016/S1081-1206(10)60597-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18450120%20AND%20SRC:MED&resulttype=core&format=json

6 January 2020

1 reference